Chloroquine, hydroxychloroquine, and COVID-19: systematic review and narrative synthesis of efficacy and safety

Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
M. takla, Kamalan Jeevaratnam

Abstract

The COVID-19 pandemic has required clinicians to urgently identify new treatment options or the re-purposing of existing drugs. Of particular interest are chloroquine (CQ) and hydroxychloroquine (HCQ). The aims of this systematic review are to systematically identify and collate 24 studies describing the use of CQ and HCQ in human clinical trials and to provide a detailed synthesis of evidence of its efficacy and safety. Of clinical trials, 100% showed no significant difference in the probability of viral transmission or clearance in prophylaxis or therapy, respectively, compared to the control group. Among observational studies employing an endpoint specific to efficacy, 58% concurred with the finding of no significant difference in the attainment of outcomes. Three-fifths of clinical trials and half of observational studies examining an indicator unique to drug safety discovered a higher probability of adverse events in those treated patients suspected of, and diagnosed with, COVID-19. Of the total papers focusing on cardiac side-effects, 44% found a greater incidence of QTc prolongation and/or arrhythmias, 44% found no evidence of a significant difference, and 11% mixed results. The strongest available evidence points toward...Continue Reading

References

Dec 1, 1996·Clinical Cardiology·M Reardon, M Malik
May 29, 2002·Thrombosis Research·Rado Nosál, Viera Jancinová
Apr 24, 2003·JAMA : the Journal of the American Medical Association·Sana M Al-KhatibRobert M Califf
May 6, 2003·Science·Marco A MarraRachel L Roper
Feb 7, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V C C ChengK Y Yuen
Aug 24, 2005·Virology Journal·Martin J VincentStuart T Nichol
Apr 18, 2006·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Chun-Yu ChenChih-Chuan Lin
Jul 27, 2007·Evidence-based Mental Health·Max Henderson, Lisa Page
Jan 6, 2009·Immunological Reviews·Shin-Ichiroh Saitoh, Kensuke Miyake
Jan 4, 2015·BMJ : British Medical Journal·Larissa ShamseerUNKNOWN PRISMA-P Group
Feb 28, 2015·Nature Reviews. Immunology·Paul A Roche, Kazuyuki Furuta
Jul 2, 2016·Acta Neurologica Scandinavica·R Hama, C L Bennett
Jun 24, 2017·Pharmacology & Therapeutics·Rama MalaviyaDebra L Laskin
Oct 25, 2017·Scientific Reports·Joy WolframMauro Ferrari
Nov 29, 2017·Biochemia Medica·Ana MlinarićVesna Šupak Smolčić
Jan 13, 2019·International Review of Cell and Molecular Biology·Jennifer L Guerriero
Feb 23, 2020·Science·Daniel WrappJason S McLellan
Feb 23, 2020·The Lancet Infectious Diseases·Ensheng DongLauren Gardner
Mar 4, 2020·Nature Microbiology·UNKNOWN Coronaviridae Study Group of the International Committee on Taxonomy of Viruses
Mar 10, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Xueting YaoDongyang Liu
Mar 29, 2020·The Journal of Clinical Investigation·Guang ChenQin Ning
Apr 3, 2020·Journal of Molecular Cell Biology·Mingxing HuangHong Shan
Apr 20, 2020·Journal of Thrombosis and Haemostasis : JTH·Litao ZhangZhenlu Zhang
Apr 23, 2020·JAMA : the Journal of the American Medical Association·Safiya RichardsonTheodoros P Zanos
Apr 25, 2020·Circulation·Julien PoissyUNKNOWN Lille ICU Haemostasis COVID-19 Group
Apr 30, 2020·Circulation. Arrhythmia and Electrophysiology·Moussa SalehLaurence M Epstein
Apr 30, 2020·European Heart Journal. Cardiovascular Pharmacotherapy·Kamalan Jeevaratnam
May 8, 2020·The New England Journal of Medicine·Joshua GelerisNeil W Schluger

❮ Previous
Next ❯

Citations

Jan 8, 2021·Nature Reviews. Rheumatology·Rosaria TalaricoMarta Mosca
Dec 17, 2020·Journal of Clinical Medicine·Vincenzo LaricciaSalvatore Amoroso
Jun 22, 2021·Frontiers in Medicine·Arjun SharmaMarkus Bosmann

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
glycosylation

Software Mentioned

BIORXIV
MEDRXIV

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.